Yu Ping Yang
About Yu Ping Yang
Yu Ping Yang is a Senior Scientist in Translational Sciences at CytomX Therapeutics, where he leads pharmacology efforts to enhance preclinical programs. He has a strong academic background with a Ph.D. in Genetics and Genomics from Duke University and extensive experience in developing preclinical models for target validation.
Current Role at CytomX Therapeutics
Currently, Yu Ping Yang serves as a Senior Scientist in Translational Sciences at CytomX Therapeutics. In this role, Yang functions as the pharmacology lead, coordinating efforts across multi-disciplinary teams to advance preclinical programs. This position emphasizes collaboration and integration of various scientific disciplines to enhance the development of therapeutic strategies.
Professional Experience
Prior to joining CytomX Therapeutics in 2021, Yu Ping Yang held several significant positions. Yang worked at AbbVie as a Senior Scientist II from 2018 to 2021, contributing to research in South San Francisco, California. Before that, Yang served as a Research Instructor in Medicine at Vanderbilt University Medical Center from 2015 to 2018. Additionally, Yang was a Postdoctoral Research Fellow at Vanderbilt from 2007 to 2014, accumulating extensive research experience.
Education and Expertise
Yu Ping Yang earned a Ph.D. in Genetics and Genomics from Duke University, where Yang studied from 2001 to 2007. Prior to this, Yang obtained a Master of Science in Zoology/Molecular Biology from National Taiwan University, studying from 1999 to 2001. Yang also holds a Bachelor of Science in Zoology from National Taiwan University, achieved from 1995 to 1999. This educational background provides a strong foundation in genetic research and molecular biology.
Research Specialization
Yang specializes in developing patient-derived xenograft and 3D patient-derived organoid pre-clinical models. These models are essential for target validation and biomarker identification in cancer research. Yang has extensive experience in in vivo pharmacology, focusing on genetically engineered mouse models (GEMMs) and xenograft models, with a strong emphasis on study design related to efficacy, pharmacokinetics, and pharmacodynamics.
Skills and Leadership
Yu Ping Yang possesses strategic and critical thinking skills, emphasizing innovative ideas and effective communication. Yang has experience managing and training small teams, highlighting a focus on hands-on skills and problem-solving capabilities. This combination of leadership and technical expertise supports Yang's contributions to advancing scientific research and development.